Physician profile
Sudha Kode
NPI 1396151718
$660.74
in general payments reported to CMS, 2019-2025
16 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $134 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $117.00 | 2024-2025 | Korlym |
| Novo Nordisk INC | $85.03 | 2024-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.81 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $48.80 | 2024 | |
| Lilly USA, LLC | $47.55 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $36.47 | 2025 | Tepezza, Prolia, Xgeva |
| Abbvie INC. | $35.50 | 2025 | |
| Amneal Pharmaceuticals LLC | $34.86 | 2025 | Unithroid |
| Radius Health, INC. | $29.03 | 2025 | Tymlos |
| Dexcom, INC. | $27.59 | 2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $23.53 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $23.20 | 2025 | Minimed 780g |
| Insulet Corporation | $22.31 | 2024 | Omnipod |
| Recordati_rare_diseases_inc. | $20.51 | 2025 | Isturisa |
| Abbott Laboratories | $20.06 | 2025 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $19.49 | 2025 | Tirosint, Licart, Flector |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudha Kode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.